2007 annual financial data
Celldex Therapeutics 2007 Operating cash flow margin
Direct answer
Operating cash flow margin was -378.27%.
Operating income was -22,854,961 USD and net income was -21,638,761 USD.
Operating cash flow was -19,302,986 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,102,930 USD
- Operating income
- -22,854,961 USD
- Net income
- -21,638,761 USD
- Operating cash flow
- -19,302,986 USD